Flow cytometry has long enabled basic and clinical ... “Today, we’re moving into minimal residual disease (MRD) and we can find that rare cell.” In 2006, the European Scientific Foundation ...

“This brings a revolutionary new advancement to the field of molecular MRD (Measurable Residual Disease) research. These assays complement our innovative flow cytometry products, such as DURAClone RE ...

To test for MRD, the study’s researchers used flow cytometry to assess fluorescently tagged antibodies bound to specific markers on the surface of cancer cells. The sensitivity of conventional ...

Driven EcosystemsDublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Test Techniques (Flow ...

It is important for practicing hematopathologists to understand the prognostic and therapeutic significance of the MRD result and be aware of the advances made in this field. Flow Cytometry is a ...

“This brings a revolutionary new advancement to the field of molecular MRD (Measurable Residual Disease) research. These assays complement our innovative flow cytometry products, such as DURAClone RE ...